Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Transplantation).php on line 2
Kidney (Transplantation)
LE WE PMID CA
Kidney (Transplantation)1989Niere (Transplantation)

Ciclosporin ttMPT

Gene expression profiling

Hemodialysis (Vascular access)

Hemolytic uremic syndrome

Hepatitis B

Human herpesvirus8

Interventional radiology

Kidney (Fibrosis)

Kidney (Proteinuria)

Kidney (Transplantation)

Liver (Transplantation)

Lymphocele

Organogenetic tolerance

Pancreas (Transplantation)

Post transplant erythrocytosis

Renal artery stenosis

Sonography (Implanted)

2002  
1
2009  
2
Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis.
[19719973] Chin Med J (Engl) 122(14): 1692-8 (2009)
2004  
3
2007  
4
The ups and downs of sirolimus in kidney transplantation, and the importance of reporting negative findings.
[17293633] Neth J Med 65(1): 3-4 (2007)
1978  
5
Clinical renal transplantation: a review.
[344878] J R Soc Med 71(1): 44-9 (1978)
2004  
6
Transplant graft vasculopathy: an emerging target for prevention and treatment of renal allograft dysfunction.
[15627297] Yonsei Med J 45(6): 1053-8 (2004)
2006  
7
A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.
[17134597] Health Technol Assess 10(49): iii-iv, ix-xi, 1-157 (2006)
2005  
8
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
[15899149] Health Technol Assess 9(21): 1-179, iii-iv (2005)
2009  
9
Management of chronic allograft nephropathy: a systematic review.
[19339427] Clin J Am Soc Nephrol 4(4): 860-5 (2009)
2009  
10
Calcineurin inhibitor nephrotoxicity.
[19218475] Clin J Am Soc Nephrol 4(2): 481-508 (2009)
2007  
11
Chronic transplant glomerulopathy: need for further assessment.
[17942764] Clin J Am Soc Nephrol 2(6): 1108-9 (2007)
2006  
12
Antibody-mediated rejection in renal allografts: lessons from pathology.
[17699240] Clin J Am Soc Nephrol 1(3): 415-20 (2006)
2006  
13
Mechanisms and role of HLA and non-HLA alloantibodies.
[17699239] Clin J Am Soc Nephrol 1(3): 404-14 (2006)
2006  
14
Beyond histology: novel tools to diagnose allograft dysfunction.
[17699232] Clin J Am Soc Nephrol 1(3): 358-66 (2006)
2009  
15
Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
[19850771] Clin J Am Soc Nephrol 4(12): 2029-34 (2009)
2005  
16
More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery.
[16172291] Arch Surg 140(9): 835-9; discussion 839-40 (2005)
1998  
17
Two hundred one consecutive living-donor nephrectomies.
[9565124] Arch Surg 133(4): 426-31 (1998)
2004  
18
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases.
[15273562] Ann Surg 240(2): 358-63 (2004)
2001  
19
2,500 living donor kidney transplants: a single-center experience.
[11505060] Ann Surg 234(2): 149-64 (2001)
1992  
20
Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys. A review of 855 operations.
[1632682] Ann Surg 215(6): 606-16; discussion 616-7 (1992)
1988  
21
Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients.
[3288138] Ann Surg 207(5): 538-48 (1988)
1979  
22
External ureteroneocystostomy and ureteroureterostomy in renal transplantation.
[389186] Ann Surg 190(5): 663-7 (1979)
1974  
23
A decade followup in early cases of renal homotransplantation.
[4606113] Ann Surg 180(4): 606-16 (1974)
1997  
24
Urological complications in renal transplantation: impact of a change of technique.
[9126075] Br J Urol 79(4): 499-502 (1997)
1976  
25
The pathology of renal homograft rejection. A review.
[187063] Am J Pathol 85(3): 773-804 (1976)
1990  
26
1971  
27
Functional aspects of the rejection of transplanted kidneys.
[4943658] Calif Med 115(6): 17-39 (1971)
1965  
28
Renal homotransplantation. Current status.
[5321391] Calif Med 103(6): 427-32 (1965)
2008  
29
Cancer screening in renal transplant recipients: what is the evidence?
[18309007] Clin J Am Soc Nephrol 3 Suppl 2(-): S87-S100 (2008)
2008  
30
Viral infection after renal transplantation: surveillance and management.
[18309006] Clin J Am Soc Nephrol 3 Suppl 2(-): S76-86 (2008)
2008  
31
Late kidney allograft loss: what we know about it, and what we can do about it.
[18309004] Clin J Am Soc Nephrol 3 Suppl 2(-): S56-67 (2008)
2008  
32
Management of cardiovascular disease in renal transplant recipients.
[18287250] Clin J Am Soc Nephrol 3(2): 491-504 (2008)
2007  
33
Transplant-associated hyperglycemia: a new look at an old problem.
[17699434] Clin J Am Soc Nephrol 2(2): 343-55 (2007)
2006  
34
Bone disease after renal transplantation.
[17699362] Clin J Am Soc Nephrol 1(6): 1300-13 (2006)
2006  
35
Medical care of kidney transplant recipients after the first posttransplant year.
[17699268] Clin J Am Soc Nephrol 1(4): 623-40 (2006)
2006  
36
Sensitization after kidney transplantation.
[17699242] Clin J Am Soc Nephrol 1(3): 433-40 (2006)
2006  
37
Presensitization: the problem and its management.
[17699241] Clin J Am Soc Nephrol 1(3): 421-32 (2006)
2006  
38
Antibody mediated rejection: update 2006.
[17699238] Clin J Am Soc Nephrol 1(3): 400-3 (2006)
2008  
39
Statin use prolongs patient survival after renal transplantation.
[18842988] J Am Soc Nephrol 19(11): 2037-40 (2008)
2005  
40
Chronic renal allograft dysfunction.
[16120819] J Am Soc Nephrol 16(10): 3015-26 (2005)
2005  
41
Viral infection in the renal transplant recipient.
[15829710] J Am Soc Nephrol 16(6): 1758-74 (2005)
2004  
42
Transplant renal artery stenosis.
[14694165] J Am Soc Nephrol 15(1): 134-41 (2004)
2002  
43
Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.
[12191988] J Am Soc Nephrol 13(9): 2420-3 (2002)
2002  
44
C4d and the fate of organ allografts.
[12191987] J Am Soc Nephrol 13(9): 2417-9 (2002)
2001  
45
Steroid-resistant kidney transplant rejection: diagnosis and treatment.
[11251032] J Am Soc Nephrol 12 Suppl 17(-): S48-52 (2001)
2000  
46
Long-term complications in renal transplantation.
[10703683] J Am Soc Nephrol 11(3): 582-8 (2000)
1995  
47
The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians.
[7579061] J Am Soc Nephrol 6(1): 1-34 (1995)
1991  
48
Recurrent diseases in the renal allograft.
[1954324] J Am Soc Nephrol 2(2): 109-21 (1991)
2000  
49
Acute renal allograft rejection: progress in understanding cellular and molecular mechanisms.
[11435662] J Postgrad Med 46(4): 293-6 (2000)
2008  
50
Marked variation in the definition and diagnosis of delayed graft function: a systematic review.
[18408075] Nephrol Dial Transplant 23(9): 2995-3003 (2008)
2008  
51
Bone disease after renal transplantation.
[18056071] Nephrol Dial Transplant 23(2): 450-8 (2008)
2007  
52
'Old-for-old'--new strategies for renal transplantation.
[17148472] Nephrol Dial Transplant 22(2): 336-41 (2007)
2006  
53
Eurotransplant kidney allocation system (ETKAS): rationale and implementation.
[16287913] Nephrol Dial Transplant 21(1): 2-3 (2006)
2003  
54
Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection.
[12637631] Nephrol Dial Transplant 18(4): 655-60 (2003)
2001  
55
Causes of death after renal transplantation.
[11477152] Nephrol Dial Transplant 16(8): 1545-9 (2001)
2000  
56
Lymphoproliferative disease post-renal transplantation.
[11096131] Nephrol Dial Transplant 15(12): 1913-6 (2000)
1997  
57
Disorders of bone and mineral metabolism after renal transplantation.
[9350667] Kidney Int 52(5): 1412-21 (1997)
1997  
58
Acute rejection of renal allografts: mechanistic insights and therapeutic options.
[9083299] Kidney Int 51(4): 1289-304 (1997)
1996  
59
1995  
60
Management of the diabetic transplant recipient.
[8544428] Kidney Int 48(5): 1660-74 (1995)
1994  
61
Chronic transplant rejection.
[7933845] Kidney Int 46(1): 266-79 (1994)
1993  
62
Infectious disease complications of renal transplantation.
[8394951] Kidney Int 44(1): 221-36 (1993)
1993  
63
Imaging of en bloc renal transplants: normal and abnormal postoperative findings.
[8416653] AJR Am J Roentgenol 160(1): 75-81 (1993)
1991  
64
Imaging of vascular complications associated with renal transplants.
[1872225] AJR Am J Roentgenol 157(3): 449-59 (1991)
1988  
65
1990  
66
Lymphocele: the spectrum of scintigraphic findings in lymphoceles associated with renal transplant.
[2213184] J Nucl Med 31(10): 1627-31 (1990)
2007  
67
Interventional radiologic management of renal transplant dysfunction: indications, limitations, and technical considerations.
[17620470] Radiographics 27(4): 1109-30 (2007)
2005  
68
Complications of renal transplantation.
[16160115] Radiographics 25(5): 1335-56 (2005)
2004  
69
Multi-detector row CT evaluation of living renal donors prior to laparoscopic nephrectomy.
[15026593] Radiographics 24(2): 453-66 (2004)
2008  
70
Are the current chronic allograft nephropathy grading systems sufficient to predict renal allograft survival?
[18853041] Braz J Med Biol Res 41(10): 896-903 (2008)
2005  
71
Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation.
[16275969] CMAJ 173(10): 1181-4 (2005)
2005  
72
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.
[16275956] CMAJ 173(10): S1-25 (2005)
2000  
73
Complications of renal transplantation: evaluation with US and radionuclide imaging.
[10835115] Radiographics 20(3): 607-22 (2000)
1990  
74
Sonography of complications in pediatric renal allografts.
[2198634] Radiographics 10(4): 687-99 (1990)
2010  
75
Use of multidetector CT in presurgical evaluation of potential kidney transplant recipients.
[20228332] Radiographics 30(2): 517-31 (2010)
2010  
76
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.
[19783341] Am J Kidney Dis 55(1): 152-67 (2010)
2009  
77
Recent developments in kidney transplantation--a critical assessment.
[19459815] Am J Transplant 9(6): 1265-71 (2009)
2009  
78
Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations.
[20009158] Ann Transplant 14(4): 61-70 (2009)
2002  
79
Identification of patients best suited for combined liver-kidney transplantation: part II.
[11910564] Liver Transpl 8(3): 193-211 (2002)
2008  
80
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis.
[18631853] Transplant Rev (Orlando) 22(1): 1-5 (2008)
2010  
81
Hepatitis B virus infection and renal transplantation.
[20712048] World J Gastroenterol 16(31): 3878-87 (2010)
2010  
82
Allograft nephrectomy after transplant failure: should it be performed in all patients returning to dialysis?
[20075065] J Am Soc Nephrol 21(2): 207-8 (2010)
2009  
83
Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation.
[19470672] J Am Soc Nephrol 20(6): 1170-1 (2009)
2009  
84
Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
[19092117] J Am Soc Nephrol 20(5): 940-9 (2009)
2009  
85
Significance and management of proteinuria in kidney transplant recipients.
[19820126] J Am Soc Nephrol 20(12): 2490-2 (2009)
2002  
86
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.1 Late infections. Pneumocystis carinii pneumonia.
[12091642] Nephrol Dial Transplant 17 Suppl 4(-): 36-9 (2002)
2002  
87
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis.
[12091644] Nephrol Dial Transplant 17 Suppl 4(-): 39-43 (2002)
2002  
88
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.8. Bone disease.
[12091645] Nephrol Dial Transplant 17 Suppl 4(-): 43-8 (2002)
2002  
89
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.1. Haematological complications. Anaemia.
[12091647] Nephrol Dial Transplant 17 Suppl 4(-): 48-9 (2002)
2002  
90
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.2. Haematological complications. Leukopenia.
[12091648] Nephrol Dial Transplant 17 Suppl 4(-): 49 (2002)
2002  
91
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.3. Haematological complications. Erythrocytosis.
[12091649] Nephrol Dial Transplant 17 Suppl 4(-): 49-50 (2002)
2002  
92
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients.
[12091650] Nephrol Dial Transplant 17 Suppl 4(-): 50-5 (2002)
2002  
93
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.11 Paediatrics (specific problems).
[12091651] Nephrol Dial Transplant 17 Suppl 4(-): 55-8 (2002)
2002  
94
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.12. Elderly (specific problems).
[12091652] Nephrol Dial Transplant 17 Suppl 4(-): 58-60 (2002)
2002  
95
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.13 Analysis of patient and graft survival.
[12091653] Nephrol Dial Transplant 17 Suppl 4(-): 60-7 (2002)
2002  
96
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.3. Cardiovascular risks. Hyperlipidaemia.
[12091631] Nephrol Dial Transplant 17 Suppl 4(-): 26-8 (2002)
2002  
97
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.4. Cardiovascular risks. Post-transplant diabetes mellitus.
[12091632] Nephrol Dial Transplant 17 Suppl 4(-): 28 (2002)
2002  
98
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.5. Cardiovascular risks. Hyperhomocysteinaemia.
[12091633] Nephrol Dial Transplant 17 Suppl 4(-): 28-9 (2002)
2002  
99
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.6. Cardiovascular risks. Smoking.
[12091634] Nephrol Dial Transplant 17 Suppl 4(-): 29 (2002)
2002  
100
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.7. Cardiovascular risks. Obesity and weight gain.
[12091635] Nephrol Dial Transplant 17 Suppl 4(-): 29-30 (2002)
2002  
101
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.8. Cardiovascular risks. Immunosuppressive therapy.
[12091636] Nephrol Dial Transplant 17 Suppl 4(-): 30-1 (2002)
2002  
102
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment.
[12091638] Nephrol Dial Transplant 17 Suppl 4(-): 31-3, 35-6 (2002)
2002  
103
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment.
[12091640] Nephrol Dial Transplant 17 Suppl 4(-): 31-6 (2002)
2002  
104
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment.
[12091641] Nephrol Dial Transplant 17 Suppl 4(-): 32, 34-6 (2002)
2002  
105
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.3 Chronic graft dysfunction. Non-alloimmune factors.
[12091619] Nephrol Dial Transplant 17 Suppl 4(-): 11-5 (2002)
2002  
106
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.4. Chronic graft dysfunction. De novo renal disease after transplantation.
[12091620] Nephrol Dial Transplant 17 Suppl 4(-): 15-6 (2002)
2002  
107
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.5. Chronic graft dysfunction. Late recurrence of primary glomerulonephritides.
[12091621] Nephrol Dial Transplant 17 Suppl 4(-): 16-8 (2002)
2002  
108
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.6. Chronic graft dysfunction. Late recurrence of other diseases.
[12091622] Nephrol Dial Transplant 17 Suppl 4(-): 18-9 (2002)
2002  
109
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.1 Long-term immunosuppression. Late steroid or cyclosporine withdrawal.
[12091624] Nephrol Dial Transplant 17 Suppl 4(-): 19-20 (2002)
2002  
110
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.2. Long-term immunosuppression. Therapy conversion.
[12091625] Nephrol Dial Transplant 17 Suppl 4(-): 20-1 (2002)
2002  
111
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.3. Long-term immunosuppression. Toxicity of immunosuppression.
[12091626] Nephrol Dial Transplant 17 Suppl 4(-): 21-3 (2002)
2002  
112
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.4. Long-term immunosuppression. Non-compliance.
[12091627] Nephrol Dial Transplant 17 Suppl 4(-): 23-4 (2002)
2002  
113
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.1. Cardiovascular risks. Cardiovascular disease after renal transplantation.
[12091628] Nephrol Dial Transplant 17 Suppl 4(-): 24-5 (2002)
2002  
114
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.2. Cardiovascular risks. Arterial hypertension.
[12091630] Nephrol Dial Transplant 17 Suppl 4(-): 25-6 (2002)
2002  
115
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.1. Organization of follow-up of transplant patients after the first year.
[12091614] Nephrol Dial Transplant 17 Suppl 4(-): 3-4 (2002)
2002  
116
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.2 Chronic graft dysfunction. Immunological factors (alloimmunity).
[12091618] Nephrol Dial Transplant 17 Suppl 4(-): 8-11 (2002)
2002  
117
Preparation of the dialysis patient for transplantation.
[11917044] Nephrol Dial Transplant 17(4): 552-6 (2002)
2005  
118
Steroid sparing strategies in renal transplantation.
[16105871] Nephrol Dial Transplant 20(10): 2028-31 (2005)
2004  
119
Monoclonal antibodies in renal transplantation: old and new.
[14736949] Nephrol Dial Transplant 19(2): 297-300 (2004)
2009  
120
Long-term outcome after renal transplantation in childhood.
[17687572] Pediatr Nephrol 24(3): 475-84 (2009)
2007  
121
Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children.
[17186280] Pediatr Nephrol 22(4): 496-502 (2007)
2009  
122
2009  
123
Live kidney donors - assessment and follow up.
[19458802] Aust Fam Physician 38(5): 316-20 (2009)
2007  
124
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts.
[17459952] Am J Physiol Renal Physiol 293(2): F445-55 (2007)
2010  
125
Topics in transplantation medicine for general nephrologists.
[20576830] Clin J Am Soc Nephrol 5(8): 1518-29 (2010)
2006  
126
2006  
127
Pre-emptive pediatric renal transplantation.
[17186691] Saudi J Kidney Dis Transpl 17(4): 549-58 (2006)
2010  
128
Unusual causes of obstruction to transplant ureter.
[20228519] Saudi J Kidney Dis Transpl 21(2): 310-3 (2010)
2004  
129
Interventional radiology in nephrology and urology.
[18202485] Saudi J Kidney Dis Transpl 15(3): 346-61 (2004)
2004  
130
Post-transplant erythrocytosis: a review of 47 renal transplant recipients.
[17642778] Saudi J Kidney Dis Transpl 15(4): 433-9 (2004)
2010  
131
Protocol biopsies for renal transplantation.
[20061686] Saudi J Kidney Dis Transpl 21(1): 1-9 (2010)
2009  
132
Transplantation: new protocols and new worries.
[19237802] Saudi J Kidney Dis Transpl 20(2): 192-7 (2009)
2009  
133
2010  
134
Does rejection have a role in lymphocele formation post renal transplantation? A single centre experience.
[20877595] Indian J Urol 26(2): 193-5 (2010)
2010  
135
Addressing racial and ethnic disparities in live donor kidney transplantation: priorities for research and intervention.
[20116653] Semin Nephrol 30(1): 90-8 (2010)
2004  
136
Histopathologic findings and classification of feline renal transplants.
[15133173] Vet Pathol 41(3): 244-56 (2004)
2004  
137
Pancreas and kidney transplantation using embryonic donor organs.
[19521554] Organogenesis 1(1): 3-13 (2004)
2010  
138
Primary care of the renal transplant patient.
[20422302] J Gen Intern Med 25(7): 731-40 (2010)
2011  
139
Urinary biomarkers in acute kidney transplant dysfunction.
[21160228] Nephron Clin Pract 118(2): c173-81; discussion c181 (2011)
2010  
140
KDIGO guidelines for care of the kidney transplant recipient.
[20460937] Nephron Clin Pract 116(1): c27-8 (2010)
2009  
141
Transplant glomerulopathy: morphology, associations and mechanism.
[19590229] Nephron Clin Pract 113(1): c1-7; discussion c7 (2009)
2010  
142
mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?
[20155724] J Nephrol 23(2): 133-42 (2010)
2011  
143
Diagnostic criteria of antibody-mediated rejection in kidney transplants.
[21738242] Nefrologia 31(4): 382-91 (2011)
2011  
144
Clinical evidence on the use of anti-mTOR drugs in renal transplantation.
[21270910] Nefrologia 31(1): 27-34 (2011)
2010  
145
Accommodation in renal transplantation: unanswered questions.
[20613524] Curr Opin Organ Transplant 15(4): 481-5 (2010)
2010  
146
Noninvasive diagnosis of acute rejection of renal allografts.
[19935064] Curr Opin Organ Transplant 15(1): 35-41 (2010)
2009  
147
Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation.
[20676276] Curr Cardiol Rev 5(3): 177-86 (2009)
2008  
148
Lymphocele after kidney transplantation: where are we standing now?
[18825619] Urol J 5(3): 144-8 (2008)
2004  
149
The newest medications in kidney transplantation and their mechanisms of action.
[17874406] Urol J 1(1): 19-23 (2004)
2010  
150
What have we learnt from experimental renal transplantation?
[20389125] Nephron Exp Nephrol 115(1): e9-e14 (2010)
2011  
151
Impact of cigarette smoking on kidney transplant recipients: a systematic review.
[21525572] Iran J Kidney Dis 5(3): 141-8 (2011)
2009  
152
Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis.
[19617659] Iran J Kidney Dis 3(3): 121-6 (2009)
2011  
153
The use of an implantable Doppler flow probe in kidney transplantation: first report in the literature.
[21453229] Exp Clin Transplant 9(2): 118-20 (2011)
2011  
154
Strategies for successfully establishing a kidney transplant in a mouse model.
[21967253] Exp Clin Transplant 9(5): 287-94 (2011)
2008  
155
Long-term donor outcomes after living kidney donation.
[18954300] Exp Clin Transplant 6(3): 215-23 (2008)
2009  
156
Fibrogenesis in kidney transplantation: potential targets for prevention and therapy.
[19935366] Transplantation 88(10): 1149-56 (2009)
2010  
157
Cardiac evaluation prior to kidney transplantation.
[20636926] Semin Dial 23(3): 324-9 (2010)
2010  
158
The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians.
[20535263] Indian J Nephrol 20(1): 2-8 (2010)
2011  
159
Transluminal angioplasty of transplanted renal artery stenosis: a review of the literature for its safety and efficacy.
[21559256] J Transplant 2011(-): 693820 (2011)
2011  
160
Advances of genomic science and systems biology in renal transplantation: a review.
[21318414] Semin Immunopathol 33(2): 211-8 (2011)
2011  
161
Steroids in kidney transplant patients.
[21331501] Semin Immunopathol 33(2): 157-67 (2011)
2009  
162
Proximal tubular dysfunction as an indicator of chronic graft dysfunction.
[19287901] Braz J Med Biol Res 42(3): 229-36 (2009)
2010  
163
Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy.
[20688906] J Mol Diagn 12(5): 653-63 (2010)
2010  
164
Calcineurin inhibitor-induced renal allograft nephrotoxicity.
[21293540] Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154(4): 297-306 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Transplantation).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Kidney (Transplantation).php on line 92